We are live on
!
Find out more
Arrowstreet Capital Portfolio holdings
AUM
$185B
1-Year Est. Return
39.58%
This Fund
S&P 500
This Quarter
Est. Return
+8.74%
1 Year Est. Return
+39.58%
3 Year Est. Return
+145.48%
5 Year Est. Return
+192.07%
10 Year Est. Return
+749.68%
AUM
$19.4B
AUM Growth
+$2.92B
(+18%)
Cap. Flow
+$1.81B
Cap. Flow
% of AUM
9.28%
Top 10 Holdings %
Top 10 Hldgs %
20.62%
Holding
1,394
New
273
Increased
343
Reduced
316
Closed
453
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$694M |
| 2 |
Philip Morris
PM
|
+$316M |
| 3 |
Johnson & Johnson
JNJ
|
+$315M |
| 4 |
Merck
MRK
|
+$303M |
| 5 |
APC
Anadarko Petroleum
APC
|
+$235M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$248M |
| 2 |
Micron Technology
MU
|
+$212M |
| 3 |
RAD
Rite Aid Corporation
RAD
|
+$196M |
| 4 |
Comcast
CMCSA
|
+$165M |
| 5 |
GSK
GSK
|
+$149M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.45% |
| 2 | Energy | 18.88% |
| 3 | Healthcare | 17.92% |
| 4 | Financials | 10.19% |
| 5 | Consumer Staples | 7.73% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
476
Zebra Technologies
ZBRA
$17.8B
| $3.63M | 0.02% |
+44,163
| New | +$3.22M |
|
|
SNP
477
DELISTED
CHINA PETROLEUM & CHEMICAL CORPORATION ADS (REP 100 ORDINARY H SHARES)
SNP
| $3.62M | 0.02% |
+38,047
| New | +$3.49M |
|
|
CRESY
478
Cresud
CRESY
$773M
| $3.6M | 0.02% |
312,887
+102,564
| +49% | +$1.06M |
|
479
Banco Bilbao Vizcaya Argentaria
BBVA
$156B
| $3.59M | 0.02% |
+295,660
| New | +$3.55M |
|
|
WIN
480
DELISTED
Windstream Holdings Inc
WIN
| $3.54M | 0.02% |
+45,349
| New | +$3.31M |
|
481
Lazard
LAZ
$4.31B
| $3.5M | 0.02% |
+67,826
| New | +$3.34M |
|
482
Teva Pharmaceuticals
TEVA
$41.2B
| $3.49M | 0.02% |
+66,614
| New | +$3.4M |
|
|
LTM
483
DELISTED
LATAM Airlines Group S.A American Depositary Shares (Each representing 1 Common Share)
LTM
| $3.47M | 0.02% |
258,487
+213,014
| +468% | +$3.12M |
|
484
Corning
GLW
$143B
| $3.47M | 0.02% |
157,923
-1,222,606
| -89% | -$25.9M |
|
485
Gran Tierra Energy
GTE
$317M
| $3.45M | 0.02% |
42,350
+40,235
| +1,902% | +$2.96M |
|
|
VE
486
DELISTED
VEOLIA ENVIRONNEMENT
VE
| $3.43M | 0.02% |
180,673
-12,997
| -7% | -$250K |
|
|
HRC
487
DELISTED
HILL-ROM HOLDINGS, INC.
HRC
| $3.42M | 0.02% |
+82,508
| New | +$3.21M |
|
|
FISV
488
Fiserv Inc
FISV
$27.9B
| $3.4M | 0.02% |
+112,682
| New | +$3.34M |
|
489
Aflac
AFL
$62.6B
| $3.38M | 0.02% |
+108,750
| New | +$3.39M |
|
490
Allison Transmission
ALSN
$9.82B
| $3.38M | 0.02% |
+108,780
| New | +$3.29M |
|
|
PTRY
491
DELISTED
PANTRY INC (THE)
PTRY
| $3.31M | 0.02% |
204,399
+25,580
| +14% | +$398K |
|
492
Lattice Semiconductor
LSCC
$18.5B
| $3.27M | 0.02% |
396,652
-470,649
| -54% | -$3.81M |
|
|
CAMP
493
DELISTED
CalAmp Corp.
CAMP
| $3.25M | 0.02% |
6,523
+778
| +14% | +$365K |
|
494
MillerKnoll
MLKN
$1.67B
| $3.24M | 0.02% |
+107,029
| New | +$3.32M |
|
495
Tootsie Roll Industries
TR
$2.98B
| $3.23M | 0.02% |
156,634
-122,089
| -44% | -$2.46M |
|
|
ULTI
496
DELISTED
Ultimate Software Group Inc
ULTI
| $3.21M | 0.02% |
23,268
+18,113
| +351% | +$2.3M |
|
497
CEMIG Preferred Shares
CIG
$6.01B
| $3.21M | 0.02% |
788,379
+757,667
| +2,467% | +$2.88M |
|
498
US Bancorp
USB
$99.6B
| $3.18M | 0.02% |
+73,347
| New | +$3.06M |
|
|
BTM
499
DELISTED
OI S.A. SPON ADR REPSTG 3 PFD SHS (BRA)
BTM
| $3.16M | 0.02% |
3,683,574
+1,308,809
| +55% | +$1.12M |
|
|
ATHN
500
DELISTED
Athenahealth, Inc.
ATHN
| $3.14M | 0.02% |
25,064
+21,878
| +687% | +$2.83M |
|
Similar funds
VGA
Arrowstreet Capital's Q2 2014 Portfolio in Review
As of Q2 2014, Arrowstreet Capital held 1,394 positions worth $19.4B, up 18% from $16.5B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
Arrowstreet Capital deployed $1.81B of net new capital in Q2 2014, opening 273 new positions and adding to 343 existing holdings. Its largest new stake was Johnson & Johnson: 3,117,484 shares worth $326M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 22% a quarter earlier, followed by Energy and Healthcare.
On the sell side, the largest reduction was Gilead Sciences, an estimated $248M trimmed.
- Arrowstreet Capital's largest Q2 2014 buy was Johnson & Johnson: 3,117,484 shares worth $326M.
- Arrowstreet Capital added most to Apple in Q2 2014, an estimated $694M increase.
- Arrowstreet Capital's biggest Q2 2014 reduction was Gilead Sciences, cutting an estimated $248M.
- Arrowstreet Capital fully exited Comcast in Q2 2014, selling an estimated $165M.
- Arrowstreet Capital's ten largest holdings make up 21% of its $19.4B portfolio in Q2 2014.
- Arrowstreet Capital opened 273 new positions and closed 453 in Q2 2014.
- Arrowstreet Capital's portfolio value rose 18% quarter-over-quarter to $19.4B.
Based on Arrowstreet Capital's 13F filing for Q2 2014, filed 14 Aug 2014.